Spatial-domain interferometer for measuring plasma mirror expansion

International audienceWe present a practical spatial-domain interferometer for characterizing the electronic density gradient of laser- induced plasma mirrors with sub-30-femtosecond temporal resolution. Time-resolved spatial imaging of an intensity- shaped pulse reflecting off an expanding plasma mirror in- duced by a time-delayed pre-pulse allows us to measure characteristic plasma gradients of 10–100 nm with an ex- pansion velocity of 10.8 nm/ps. Spatial-domain interferom- etry (SDI) can be generalized to the ultrafast imaging of nm to μm size laser-induced phenomena at surfaces

Production of Ultra-Cold-Neutrons in Solid \alpha-Oxygen

Our recent neutron scattering measurements of phonons and magnons in solid \alpha-oxygen have led us to a new understanding of the production mechanismen of ultra-cold-neutrons (UCN) in this super-thermal converter. The UCN production in solid \alpha-oxygen is dominated by the excitation of phonons. The contribution of magnons to UCN production becomes only slightly important above E >10 meV and at E >4 meV. Solid \alpha-oxygen is in comparison to solid deuterium less effcient in the down-scattering of thermal or cold neutrons into the UCN energy regime.Comment: 4 pages, 5 figuer

Dualities and dilemmas: contending with uncertainty in large-scale safety-critical projects

© 2016, Informa UK Limited, trading as Taylor & Francis Group. Uncertainty is a fact of project life. Most decisions that are made on a safety-critical project involve uncertainty, the consequences of which may be highly significant to the safe and timely delivery of the project. Based on interviews with project management practitioners on nine large-scale civil nuclear and aerospace projects, we explore how uncertainty emerges, and how project management practitioners identify, analyse and act on it. We make three important contributions. First, we present three approaches – structural, behavioural and relational – that individuals and organizations can adopt when contending with project uncertainty. Secondly, we characterize nine dualities at play in the management of project uncertainty and thirdly, we identify key differences between how civil nuclear and aerospace project managers confront project uncertainty, which have important implications for how projects might be organized in both these industry sectors. Drawing attention to the structural, behavioural and relational approaches to project uncertainty and the tensions that manifest themselves in each approach should enable the project management community to make progress in environments of high uncertainty where situations are often complex, rapidly changing and confusing, and yet where, for reasons of safety, failure is not an option

Timing and Tempo of Early and Successive Adaptive Radiations in Macaronesia

The flora of Macaronesia, which encompasses five Atlantic archipelagos (Azores, Canaries, Madeira, Cape Verde, and Salvage), is exceptionally rich and diverse

Intravesical Treatments of Bladder Cancer: Review

For bladder cancer, intravesical chemo/immunotherapy is widely used as adjuvant therapies after surgical transurethal resection, while systemic therapy is typically reserved for higher stage, muscle-invading, or metastatic diseases. The goal of intravesical therapy is to eradicate existing or residual tumors through direct cytoablation or immunostimulation. The unique properties of the urinary bladder render it a fertile ground for evaluating additional novel experimental approaches to regional therapy, including iontophoresis/electrophoresis, local hyperthermia, co-administration of permeation enhancers, bioadhesive carriers, magnetic-targeted particles and gene therapy. Furthermore, due to its unique anatomical properties, the drug concentration-time profiles in various layers of bladder tissues during and after intravesical therapy can be described by mathematical models comprised of drug disposition and transport kinetic parameters. The drug delivery data, in turn, can be combined with the effective drug exposure to infer treatment efficacy and thereby assists the selection of optimal regimens. To our knowledge, intravesical therapy of bladder cancer represents the first example where computational pharmacological approach was used to design, and successfully predicted the outcome of, a randomized phase III trial (using mitomycin C). This review summarizes the pharmacological principles and the current status of intravesical therapy, and the application of computation to optimize the drug delivery to target sites and the treatment efficacy